Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deniz Can

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Archives of Gynecology and Obstetrics|January 10, 2012
A case with vesicouterine fistula: mini reviewMehmet Onur Karaltı, Şivekar Tınar, Nilgün Turhan Öztürk, et al.
Clinical Nutrition ESPEN|August 24, 2024
Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysisTaha Koray Sahin, Deniz Can Guven
Revista Da Associacao Medica Brasileira (1992)|September 24, 2025
Is the use of vaginal progesterone a factor in pregnant women diagnosed with gestational diabetes mellitus?Ayşe Rabia Kanbak, Deniz Can Öztekin
Breast Cancer Research and Treatment|January 19, 2024
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin
Cureus|September 15, 2022
Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case ReportHakan Taban, Deniz Can Guven, Saadettin Kılıçkap
Brain and Language|January 1, 2013
Early gray-matter and white-matter concentration in infancy predict later language skills: a whole brain voxel-based morphometry studyDilara Deniz Can, Todd Richards, Patricia K Kuhl
Expert Review of Anticancer Therapy|March 13, 2025
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitorsTaha Koray Sahin, Sercan Aksoy, Deniz Can Guven
Cancers|January 11, 2024
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung CancerDeniz Can Guven, Taha Koray Sahin, Saadettin Kilickap
Journal of Cancer Survivorship : Research and Practice|January 4, 2024
Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping reviewDeniz Can Güven, Melissa Sy Thong, Volker Arndt
Cureus|July 19, 2021
Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature ReviewEcem Yigit, Deniz Can Guven, Sercan Aksoy, et al.
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Archives of Gynecology and Obstetrics|January 10, 2012
A case with vesicouterine fistula: mini reviewMehmet Onur Karaltı, Şivekar Tınar, Nilgün Turhan Öztürk, et al.
Clinical Nutrition ESPEN|August 24, 2024
Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysisTaha Koray Sahin, Deniz Can Guven
Revista Da Associacao Medica Brasileira (1992)|September 24, 2025
Is the use of vaginal progesterone a factor in pregnant women diagnosed with gestational diabetes mellitus?Ayşe Rabia Kanbak, Deniz Can Öztekin
Breast Cancer Research and Treatment|January 19, 2024
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin
Cureus|September 15, 2022
Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case ReportHakan Taban, Deniz Can Guven, Saadettin Kılıçkap
Brain and Language|January 1, 2013
Early gray-matter and white-matter concentration in infancy predict later language skills: a whole brain voxel-based morphometry studyDilara Deniz Can, Todd Richards, Patricia K Kuhl
Expert Review of Anticancer Therapy|March 13, 2025
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitorsTaha Koray Sahin, Sercan Aksoy, Deniz Can Guven
Cancers|January 11, 2024
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung CancerDeniz Can Guven, Taha Koray Sahin, Saadettin Kilickap
Journal of Cancer Survivorship : Research and Practice|January 4, 2024
Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping reviewDeniz Can Güven, Melissa Sy Thong, Volker Arndt
Cureus|July 19, 2021
Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature ReviewEcem Yigit, Deniz Can Guven, Sercan Aksoy, et al.
Pageof 20